MOUNJARO FOR TYPE 2 DIABETES

Why diabetes and weight are treated together

In type 2 diabetes, excess weight and insulin resistance reinforce each other. Treating glucose without addressing weight leaves the underlying driver in place, and some older diabetes medicines cause weight gain, which worsens the loop.

Medicines that improve glucose control while reducing weight break that pattern rather than managing one side of it.

This is why the arrival of GLP-1 and dual-agonist medicines changed how type 2 diabetes with obesity is approached.

How tirzepatide works on glucose

Tirzepatide activates both GIP and GLP-1 receptors. It stimulates insulin release when blood glucose is raised, suppresses glucagon, and slows gastric emptying so glucose enters the bloodstream more gradually after meals.

Because insulin release is glucose-dependent, the medicine itself carries a low risk of hypoglycaemia when used alone. The risk arises from combination with other diabetes drugs.

Published trials report substantial reductions in HbA1c alongside weight loss, which is why it was licensed for diabetes first.

Patient outcomes from supervised programmes at our clinic, published with consent and with faces obscured for privacy. Individual results vary.

Adjusting your existing medication

If you take insulin or a sulfonylurea such as glimepiride, those doses frequently need reducing when tirzepatide is added. Otherwise the combination can drive blood glucose too low.

This adjustment is a medical decision made at prescribing and revisited at each review. It is the single clearest reason why these medicines should never be obtained without a doctor.

Metformin is commonly continued alongside. Your full medication list is reviewed at assessment, including anything prescribed by another doctor.

Monitoring during treatment

Expect more frequent glucose monitoring in the early weeks, particularly if your other medication has been adjusted. Your team will tell you what readings warrant contact.

HbA1c is typically rechecked after around three months, since it reflects average control over the preceding period rather than the current day.

Reviews also cover weight, waist measurement, blood pressure, lipids, kidney and liver function.

Recognising low blood sugar

Symptoms include shakiness, sweating, unusual hunger, confusion, palpitations and irritability. If you take insulin or a sulfonylurea, you should know these and how to treat them before starting.

Keep fast-acting glucose accessible during the adjustment period, and tell someone at home what to look for.

Repeated low readings are a reason to contact your team promptly for a medication review, not to skip doses independently.

What improves beyond glucose

Patients frequently report improvements in blood pressure, triglycerides and liver markers. For those with fatty liver disease, which commonly accompanies type 2 diabetes, this is clinically meaningful.

Weight reduction can also ease sleep apnoea and joint pain, which many patients value more day to day than a change in HbA1c.

In some patients, sustained weight loss leads to a reduction in overall diabetes medication. Any such change is made by your doctor.

Who should not take it

It is not prescribed where there is a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, in pregnancy or breastfeeding, or with a history of pancreatitis.

Type 1 diabetes is a different condition and this is not a substitute for insulin. Severe kidney impairment and certain gastrointestinal conditions require careful review.

Your full history is assessed before any prescription is issued.

Coordinating with your existing doctor

If you are already under a physician or endocrinologist for diabetes, treatment is coordinated with them rather than run separately. Bring your recent reports and prescriptions to your assessment.

Fragmented care is where medication errors happen, particularly with insulin adjustments.

We are happy to communicate directly with your existing treating doctor.

What to expect in the first three months

Blood glucose readings often improve within the first few weeks, sometimes before meaningful weight change. If you take insulin or a sulfonylurea, this is precisely when hypoglycaemia risk is highest and why monitoring is stepped up.

HbA1c is usually rechecked at around three months, since it reflects average control over the preceding period rather than the present day.

Weight change follows the usual pattern: modest in month one during titration, clearer through months two and three.

Blood pressure and triglycerides frequently improve alongside, which matters because cardiovascular risk rather than glucose alone is what drives long-term outcomes in type 2 diabetes.

Monitoring your glucose at home

Your team should tell you how often to test during the adjustment period and which readings warrant contact. This is more frequent at the start than later.

Record readings alongside what you ate and when you injected. Patterns emerge from this that a single reading cannot show, and it makes review appointments considerably more productive.

Keep fast-acting glucose accessible throughout the adjustment phase, and make sure someone at home knows the symptoms of a low and how to help.

Repeated low readings mean your other medication needs reviewing promptly. They are not a reason to skip your weekly injection independently.

Diabetes-specific nutrition considerations

The protein-forward approach applies as it does for anyone on this medicine, but carbohydrate distribution matters more here. Spreading carbohydrate across meals rather than concentrating it produces steadier readings.

Reduced appetite can lead to skipped meals, which is riskier if you take insulin or a sulfonylurea. Eating small and regular is safer than eating little and erratically.

Alcohol carries additional hypoglycaemia risk in patients on insulin, particularly when combined with reduced food intake.

Your dietitian should build the plan around your diabetes medication schedule, not separately from it.

Frequently asked questions